Full text is available at the source.
Abstract
Essence
Adenine base editing may correct the recurrent MMAB c.556C>T (R186W) methylmalonic acidemia variant in hepatocytes.
Evidence
This was an in vitro gene-editing platform experiment using adenine base editor mRNA, optimized hybrid guide RNA, and lipid nanoparticles to edit hepatocytes.
Caveat
The abstract reports hepatocyte editing rather than animal or patient outcomes, so therapeutic delivery, durability, safety, and clinical benefit remain untested.
Simplified